All treatments
Treatment
Cretostimogene Grenadenorepvec clinical trials
2 indexed studies · 0 currently recruiting
- Active not recruitingPHASE3
A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT
This study looks at a new treatment called cretostimogene grenadenorepvec for a type of bladder cancer that hasn't spread into the muscle. It compares giving this treatment after surgery to just monitoring patients. The aim is to see if the new treatment can stop the cancer from coming back.
For: Non Muscle Invasive Bladder Cancer · Urologic Cancer · Bladder CancerUnited States · Canada - Active not recruitingPHASE3
Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin
This study is testing a new treatment, cretostimogene, for a type of bladder cancer that hasn't responded to usual treatments like BCG. It's for people with non-muscle invasive bladder cancer, specifically high-grade types. The aim is to see how well it works.
For: Non Muscle Invasive Bladder Cancer · High-grade Ta/ T1 Papillary Disease Bladder CancerUnited States · Australia · Canada